Courtenay M Holscher1, Christine E Haugen1, Kyle R Jackson1, Jacqueline M Garonzik Wang1, Madeleine M Waldram1, Sunjae Bae1,2, Jayme E Locke3, Rhiannon D Reed3, Krista L Lentine4, Gaurav Gupta5, Matthew R Weir6, John J Friedewald7, Jennifer Verbesey8, Matthew Cooper8, Dorry L Segev9,2, Allan B Massie1,2. 1. Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland. 2. Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland. 3. Comprehensive Transplant Institute, University of Alabama at Birmingham, Birmingham, Alabama. 4. Saint Louis University Center for Abdominal Transplantation, St. Louis, Missouri. 5. Department of Medicine, Virginia Commonwealth University, Richmond, Virginia. 6. Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland. 7. Comprehensive Transplant Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois; and. 8. MedStar Georgetown Transplant Institute, MedStar Georgetown University Hospital, Washington, DC. 9. Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland; dorry@jhmi.edu.
Abstract
BACKGROUND AND OBJECTIVES: The risk of hypertension attributable to living kidney donation remains unknown as does the effect of developing postdonation hypertension on subsequent eGFR. We sought to understand the association between living kidney donation, hypertension, and long-term eGFR by comparing donors with a cohort of healthy nondonors. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We compared 1295 living kidney donors with median 6 years of follow-up with a weighted cohort of 8233 healthy nondonors. We quantified the risk of self-reported hypertension using a parametric survival model. We examined the association of hypertension with yearly change in eGFR using multilevel linear regression and clustering by participant, with an interaction term for race. RESULTS: Kidney donation was independently associated with a 19% higher risk of hypertension (adjusted hazard ratio, 1.19; 95% confidence interval, 1.01 to 1.41; P=0.04); this association did not vary by race (interaction P=0.60). For white and black nondonors, there was a mean decline in eGFR (-0.4 and -0.3 ml/min per year, respectively) that steepened after incident hypertension (-0.8 and -0.9 ml/min per year, respectively; both P<0.001). For white and black kidney donors, there was a mean increase in eGFR after donation (+0.4 and +0.6 ml/min per year, respectively) that plateaued after incident hypertension (0 and -0.2 ml/min per year, respectively; P=0.07 and P=0.01, respectively, after hypertension). CONCLUSIONS: Kidney donors are at higher risk of hypertension than similar healthy nondonors, regardless of race. Donors who developed hypertension had a plateau in the usual postdonation increase of eGFR.
BACKGROUND AND OBJECTIVES: The risk of hypertension attributable to living kidney donation remains unknown as does the effect of developing postdonation hypertension on subsequent eGFR. We sought to understand the association between living kidney donation, hypertension, and long-term eGFR by comparing donors with a cohort of healthy nondonors. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: We compared 1295 living kidney donors with median 6 years of follow-up with a weighted cohort of 8233 healthy nondonors. We quantified the risk of self-reported hypertension using a parametric survival model. We examined the association of hypertension with yearly change in eGFR using multilevel linear regression and clustering by participant, with an interaction term for race. RESULTS: Kidney donation was independently associated with a 19% higher risk of hypertension (adjusted hazard ratio, 1.19; 95% confidence interval, 1.01 to 1.41; P=0.04); this association did not vary by race (interaction P=0.60). For white and black nondonors, there was a mean decline in eGFR (-0.4 and -0.3 ml/min per year, respectively) that steepened after incident hypertension (-0.8 and -0.9 ml/min per year, respectively; both P<0.001). For white and black kidney donors, there was a mean increase in eGFR after donation (+0.4 and +0.6 ml/min per year, respectively) that plateaued after incident hypertension (0 and -0.2 ml/min per year, respectively; P=0.07 and P=0.01, respectively, after hypertension). CONCLUSIONS: Kidney donors are at higher risk of hypertension than similar healthy nondonors, regardless of race. Donors who developed hypertension had a plateau in the usual postdonation increase of eGFR.
Keywords:
United States; confidence intervals; follow-up studies; glomerular filtration rate; hypertension; kidney; kidney donation; linear models; living donors; self report; tissue and organ harvesting
Authors: Neil Boudville; G V Ramesh Prasad; Greg Knoll; Norman Muirhead; Heather Thiessen-Philbrook; Robert C Yang; M Patricia Rosas-Arellano; Abdulrahman Housawi; Amit X Garg Journal: Ann Intern Med Date: 2006-08-01 Impact factor: 25.391
Authors: Josef Coresh; Brad C Astor; Geraldine McQuillan; John Kusek; Tom Greene; Frederick Van Lente; Andrew S Levey Journal: Am J Kidney Dis Date: 2002-05 Impact factor: 8.860
Authors: Hassan N Ibrahim; Robert Foley; LiPing Tan; Tyson Rogers; Robert F Bailey; Hongfei Guo; Cynthia R Gross; Arthur J Matas Journal: N Engl J Med Date: 2009-01-29 Impact factor: 91.245
Authors: Guruprasad Manjunath; Hocine Tighiouart; Hassan Ibrahim; Bonnie MacLeod; Deeb N Salem; John L Griffith; Josef Coresh; Andrew S Levey; Mark J Sarnak Journal: J Am Coll Cardiol Date: 2003-01-01 Impact factor: 24.094
Authors: S Anjum; A D Muzaale; A B Massie; S Bae; X Luo; M E Grams; K L Lentine; A X Garg; D L Segev Journal: Am J Transplant Date: 2016-07-12 Impact factor: 8.086
Authors: Paolo Strati; Sairah Ahmed; Partow Kebriaei; Loretta J Nastoupil; Catherine M Claussen; Grace Watson; Sandra B Horowitz; Anne Rain T Brown; Bryan Do; Maria A Rodriguez; Ranjit Nair; Elizabeth J Shpall; Michael R Green; Sattva S Neelapu; Jason R Westin Journal: Blood Adv Date: 2020-07-14
Authors: Kevin Gianaris; Grecia B Vargas; Morgan Johnson; Yifan Yu; Elena Wilson; Jamilah A Perkins; Aswad Jackson; L Ebony Boulware; Allan Massie; Macey L Levan; Dorry L Segev; Tanjala S Purnell Journal: Ethn Dis Date: 2022-04-21 Impact factor: 2.006
Authors: Hassan N Ibrahim; Sean A Hebert; Dina N Murad; Horacio E Adrogue; Duc T Nguyen; Edward A Graviss; Hana Nguyen; Arthur Matas Journal: Kidney Int Rep Date: 2021-03-03
Authors: Mavish Chaudry; Gunnar Hilmar Gislason; Emil Loldrup Fosbøl; Lars Køber; Thomas Alexander Gerds; Christian Torp-Pedersen Journal: BMJ Open Date: 2020-11-09 Impact factor: 2.692